Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > OUTLOOK THIS YEAR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(20)
•••
Comment by juansitoon May 16, 2019 3:22pm
107 Views
Post# 29752561

RE:RE:RE:RE:RE:OUTLOOK THIS YEAR

RE:RE:RE:RE:RE:OUTLOOK THIS YEARyou are rigth and wrong...

rigth they need millions to keep on going

wrong (what retailer holders dont know, including myself) negotiation are going on... and probably we going to see outcome related soon...(we dont know when)

my bet is on ico019 more than ico008 and maybe something else related to other patents they own.

I ll love to hear about a strike deal before june but june I will still be waiting...no other path for me...

I already got the chunk I can afford to lose.

but guessing I ll not...and that i m probably became richier...GLTA



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities